Factors Affecting Long-Term Survival in Patients with Recurrent Head and Neck Cancer May Help Define the Role of Post-Treatment Surveillance

被引:35
作者
Agrawal, Amit [1 ,2 ]
Hammond, Thomas H. [1 ,2 ]
Young, Gregory S. [3 ]
Avon, Amanda L. [1 ,2 ]
Ozer, Enver [1 ,2 ]
Schuller, David E. [1 ,2 ]
机构
[1] Ohio State Univ, Arthur G James Canc Hosp, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA
[2] Ohio State Univ, Arthur G James Canc Hosp, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Ohio State Univ, Arthur G James Canc Hosp, Ctr Biostat, Columbus, OH 43210 USA
关键词
Recurrent head and neck cancer; surveillance; salvage; survival; FOLLOW-UP; BREAST-CANCER; CARCINOMA;
D O I
10.1002/lary.20527
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: Assess impact of clinical variables upon survival in patients diagnosed with recurrent head and neck carcinoma and better delineate role of post-treatment surveillance. Methods: Variables including previous tumor site, stage, prior therapy, location of recurrence, patient-identified symptoms, compliance with recommended surveillance, definitive salvage therapy, and clinical outcome were recorded for patients diagnosed with recurrent head and neck cancer from which estimates of survival were generated and compared. Results: One hundred five patients were identified as having been diagnosed with recurrent disease. The majority (81%) were deemed compliant with recommended surveillance. Eighty-nine patients (85%) identified new symptoms/findings prior to diagnosis. Survival was not significantly different between compliant and noncompliant patients (P = .20). For patients who underwent salvage therapy, no significant differences in survival were seen according to original primary site or mode of treatment for recurrence. Better survival was seen in patients with original prior early stage disease (P = .0001) and in patients with local-only site of disease recurrence (P = .0001). Conclusions: In patients with recurrent disease, survival may relate more to variables associated with prior disease or recurrence location than those associated with follow-up surveillance. Surveillance and salvage therapy for recurrent disease may, however, preferentially benefit certain subgroups: 1) patients with prior early stage disease, and 2) those in whom site of recurrence is local-only. Despite high compliance with recommended surveillance, survival remains extremely poor for patients with recurrent disease previously treated for advanced stage disease or with those with regional recurrence. As such, the impact of routine surveillance upon survival in these patients remains unclear.
引用
收藏
页码:2135 / 2140
页数:6
相关论文
共 11 条
[1]   Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer [J].
Agrawal, A ;
deSilva, BW ;
Buckley, BM ;
Schuller, DE .
LARYNGOSCOPE, 2004, 114 (02) :232-+
[2]  
[Anonymous], NCCN CLIN PRACT GUID
[3]   THE VALUE OF FOLLOW-UP IN PATIENTS TREATED FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
BOYSEN, M ;
LOVDAL, O ;
TAUSJO, J ;
WINTHER, F .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :426-430
[4]   VALUE OF OUTPATIENT FOLLOW-UP AFTER CURATIVE SURGERY FOR CARCINOMA OF THE LARGE BOWEL [J].
COCHRANE, JPS ;
WILLIAMS, JT ;
FABER, RG ;
SLACK, WW .
BRITISH MEDICAL JOURNAL, 1980, 280 (6214) :593-595
[5]   INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL [J].
DELTURCO, MR ;
PALLI, D ;
CARIDDI, A ;
CIATTO, S ;
PACINI, P ;
DISTANTE, V ;
AZZINI, V ;
BELSANTI, V ;
BARTOLUCCI, R ;
DICOSTANZO, F ;
BERTUSI, M ;
DANESE, S ;
GIARDINA, G ;
DAIUTO, G ;
UCCELLO, V ;
DELEO, G ;
PUNZO, C ;
GOSSO, P ;
GRISO, C ;
LOCATELLI, E ;
MANSUTTI, M ;
SANDRI, P ;
MOLINO, AM ;
SCHINCAGLIA, P ;
TIENGHI, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (20) :1593-1597
[6]   Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients [J].
Fleming, Alfred J., Jr. ;
Smith, Stephen P., Jr. ;
Paul, Christopher M. ;
Hall, Nathan C. ;
Daly, Brett T. ;
Agrawal, Amit ;
Schuller, David E. .
LARYNGOSCOPE, 2007, 117 (07) :1173-1179
[7]  
STIERER M, 1989, CANCER-AM CANCER SOC, V64, P1128, DOI 10.1002/1097-0142(19890901)64:5<1128::AID-CNCR2820640527>3.0.CO
[8]  
2-H
[9]   Is follow-up of lung cancer patients after resection medically indicated and cost-effective? [J].
Walsh, GL ;
OConnor, M ;
Willis, KM ;
Milas, M ;
Wong, RS ;
Nesbitt, JC ;
Putnam, JB ;
Lee, JJ ;
Roth, JA .
ANNALS OF THORACIC SURGERY, 1995, 60 (06) :1563-1570
[10]   Outcome of salvage total laryngectomy following organ preservation therapy - The Radiation Therapy Oncology Group Trial 91-11 [J].
Weber, RS ;
Berkey, BA ;
Forastiere, A ;
Cooper, J ;
Maor, M ;
Goepfert, H ;
Morrison, W ;
Glisson, B ;
Trotti, A ;
Ridge, JA ;
Chao, KSC ;
Peters, G ;
Lee, DJ ;
Leaf, A ;
Ensley, J .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (01) :44-49